ALCAM and colorectal carcinoma: To study the involvement of ALCAM/CD166 in the interactions and ensuing uptake of EVs produced by OvC (SKOV-3) and CRC (Colo-320) cells, we first suppressed the expression of this molecule in both cancer cell lines by using the CRISPR/Cas9 gene knock out technique.